Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Ata de Congresso
|
CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized studyBourhis, JH ; Bouko, Y ; Koscielny, S ; Greinix, H ; Derigs, G ; Salles, G ; Feremans, W ; Bakkus, M ; Apperley, J ; Samson, D ; Gahrton, G ; Pico, JL ; Goldschmidt, HBLOOD, 2003, Vol.102 (11), p.988A [Periódico revisado por pares]Texto completo disponível |
|
2 |
Material Type: Ata de Congresso
|
CD34+selected PBPCT results in an increased infective risk without prolongation of event free survival in newly diagnosed myeloma: A randomised study from the EBMTGoldschmidt, H ; Bouko, Y ; Bourhis, JH ; Greinix, H ; Salles, G ; Derigs, G ; Feremans, W ; Hegenbart, U ; Bakkus, M ; Samson, D ; Gahrton, G ; Pico, JL ; Apperley, JBLOOD, 2000, Vol.96 (11), p.558A [Periódico revisado por pares]Texto completo disponível |